Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-008029
Filing Date
2004-03-15
Accepted
2004-03-15 17:03:53
Documents
16
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2130498z10-k.htm 10-K 1524235
3 EXHIBIT 4.3 a2130498zex-4_3.txt EX-4.3 388792
4 EXHIBIT 4.4 a2130498zex-4_4.txt EX-4.4 98615
5 EXHIBIT 10.41 a2130498zex-10_41.txt EX-10.41 28205
6 EXHIBIT 10.42 a2130498zex-10_42.txt EX-10.42 17756
7 EXHIBIT 10.43 a2130498zex-10_43.txt EX-10.43 20181
8 EXHIBIT 10.44 a2130498zex-10_44.txt EX-10.44 2694
9 EXHIBIT 10.45 a2130498zex-10_45.txt EX-10.45 114315
10 EXHIBIT 10.46 a2130498zex-10_46.txt EX-10.46 16682
11 EXHIBIT 10.47 a2130498zex-10_47.txt EX-10.47 13152
12 EXHIBIT 14.1 a2130498zex-14_1.txt EX-14.1 38579
13 EXHIBIT 21.1 a2130498zex-21_1.txt EX-21.1 3673
14 EXHIBIT 23.1 a2130498zex-23_1.txt EX-23.1 815
15 EXHIBIT 31.1 a2130498zex-31_1.txt EX-31.1 3123
16 EXHIBIT 31.2 a2130498zex-31_2.txt EX-31.2 3156
17 EXHIBIT 32.1 a2130498zex-32_1.txt EX-32.1 2462
  Complete submission text file 0001047469-04-008029.txt   2279791
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16789 | Film No.: 04670279
SIC: 2835 In Vitro & In Vivo Diagnostic Substances